@article{b7e0fd620de24f728fe8a79e06935899,
title = "Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics",
keywords = "Anti-inflammatory, Anti-oxidant, Asthma, Curcumin, Moderate asthma, Severe asthma, COVID-19 Drug Treatment, SARS-CoV-2/isolation \& purification, Humans, Male, Leukocyte Count/methods, Curcumin/administration \& dosage, COVID-19/diagnosis, Antioxidants/administration \& dosage, Anti-Inflammatory Agents, Non-Steroidal/administration \& dosage, Asthma/blood, Immunoglobulin E/blood, Adult, Female, Severity of Illness Index, Ambulatory Care/methods, Double-Blind Method, Administration, Oral, Randomized Controlled Trials as Topic, Drug Monitoring/methods, Clinical Trials, Phase II as Topic, Eosinophils",
author = "Michele Quan and Abdullah Alismail and Noha Daher and Derrick Cleland and Sonia Chavan and Tan, \{Laren D.\}",
note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",
year = "2021",
month = aug,
day = "17",
doi = "10.1186/s12890-021-01619-y",
language = "English",
volume = "21",
journal = "BMC Pulmonary Medicine",
issn = "1471-2466",
number = "1",
}